Anja Pedersen

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Christian Winther Eskelund, Christina Dahl, Jakob Werner Hansen et al. · Blood · 2017 · 396 citations · Full text

Medicine, Hematology, Oncology +14

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Simon Husby, Christian Garde, Roza Zandi et al. · Blood · 2015 · 52 citations · Full text

Medicine, Molecular Medicine, Oncology +17

C-Terminally PEGylated hGH-derivatives

Bernd Peschke, Magali Zundel, Sonja Bak et al. · Bioorganic & Medicinal Chemistry · 2007 · 29 citations

Diffuse large B-cell lymphoma with combined<i>TP53</i>mutation and<i>MIR34A</i>methylation: Another “double hit” lymphoma with very poor outcome?

Fazila Asmar, Christoffer Hother, Gorjan Kulosman et al. · Oncotarget · 2014 · 26 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Helga D. Munch‐Petersen, Fazila Asmar, Konstantinos Dimopoulos et al. · Acta Neuropathologica Communications · 2016 · 22 citations · Full text

Medicine, Genetics, Oncology +17